Treatment-resistant depression: therapeutic trends, challenges, and future directions

Cited by (794)

Items 501–600 of 794

1. A Comparison Between the Effectiveness of Acceptance and Commitment Treatment and Behavioral Activation Treatment for Depression on Symptoms Severity and Rumination Among Patients with Treatment-Resistant Depression
   Rahim Bagherzadeh Ladari, Abbas Masjedi Arani, Maryam Bakhtiari, Mehran Zarghami, Robabeh Nouri, Seyed Hamzeh Hosseini · 2018 · Iranian Journal of Psychiatry and Behavioral Sciences
2. Design, synthesis, and molecular docking of new 5-HT reuptake inhibitors based on modified 1,2-dihydrocyclopenta[b]indol-3(4H)-one scaffold
   Milena Szewczyk, Paweł Punda, Karolina Janikowska, Sławomir Makowiec · 2019 · Journal of Chemical Sciences
3. Ketamine; A better anti-depressant? An animal study evaluating the efficacy of citalopram, ketamine and their combination in animal models of depression
   Salim Sheikh, Sonone Pankaj, Verma Veena, Chakra Dhar Tripathi, Karim Bushra Ahmed, Girish Gulab Meshram · 2021 · Journal of Neurology Neurological Science and Disorders
4. Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder
   Tarika Nagi, Amit Jagtiani, Saurabh Somvanshi, Satesh A Seegobin, Jasbir Singh, Anil Krishna Bachu, Meenal Pathak · 2023 · Cureus
5. The Treatment of Nonmelancholic Depression: When Antidepressants Fail, Does Psychotherapy Work?
   Gordon Barraclough Parker, Rebecca Graham, Elizabeth Sheppard · 2014 · The Canadian Journal of Psychiatry
6. A Case of Corticosteroid-Responsive Depression
   Elizabeth Vidal, Jonathan T. Stewart, Glenn Catalano · 2013 · Psychosomatics
7. Patient with Major Depressive Disorder Responds to L-Methylfolate Post-Genetic Testing
   Therese Jaeckle · 2014 · Journal of Depression & Anxiety
8. An Interventional Study on the Clinical Usefulness and Outcomes of Electroconvulsive Therapy in Medication-Resistant Mental Disorders
   Rameshwar Singh Manhas, Raheel Mushtaq, Shah Faisal Ahmad Tarfarosh, Sheikh Shoib, Mohammad Maqbool Dar, Arshad Hussain, Tabindah Shah, Sahil Shah, Mushbiq Manzoor · 2016 · Cureus
9. Landmarks of pharmacogenomics and some considerations for clinical practice
   David Nana Ampong · 2019 · Therapeutic Advances in Psychopharmacology
10. Clinical applications of EEG power spectra aperiodic component analysis: a mini-review
    Sara Maria Pani, Luca Saba, Matteo Fraschini · 2022
11. Neuroimaging signatures and a deep learning modeling for early diagnosing and predicting non-pharmacological therapy success for subclinical depression comorbid sleep disorders in college students
    Xinyu Liang, Yunan Guo, Hanyue Zhang, Xiaotong Wang, Danian Li, Yujie Liu, Jianjia Zhang, Luping Zhou, Shijun Qiu · 2024 · International Journal of Clinical and Health Psychology
12. Grape Seed Extract Pretreatment Prevents Mitochondrial Dysfunction and NLRP3 Inflammasome-Induced Inflammatory Response in Glial Cells Exposed to Paroxetine and Quinolinic Acid
    Marina Rigotti, Laura Ferrazzi Finger, Fernando Joel Scariot, Alencar Kolinski Machado, Scheila de Ávila e Silva, Mirian Mendonça Salvador, Cátia Santos Branco · 2025 · Molecular Neurobiology
13. Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors
    Jazmine D. W. Yaeger, Megan M. John, Leighton J. Ledesma, Kevin T. Krupp, Clarissa D. Booth, N. Jones, Aisel Valiño, Nathan Popp, Monica Sathyanesan, Samuel Sathyanesan Newton et al. · 2025 · Neuropharmacology
14. Assessing adult zebrafish despair-like behaviors in the small vertical cylinder immobility test (VCIT)
    Jiyi Wang, Vea Bley, Jiayou Jiang, Yun‐Qian Zhang, Yixing Qin, Haoyu Feng, Yucheng Liu, Ruiyu Li, Chaoming Wang, Shulei He et al. · 2025 · Journal of Neuroscience Methods
15. Metagenomic analysis of the gut microbiota in major depressive disorder with different antidepressant efficacy: A prospective cohort study
    Jia-Yu Du, Fang-lin Qin, Runnan Yang, Yilong Chen, Guifeng Tan, Wenjing Li, Lin Yang, Jia Cheng Cai, Dan-Lin Shen, Hongru Zhu et al. · 2025 · Journal of Affective Disorders
16. Long-term effectiveness and side-effects of intranasal esketamine in treatment-resistant depression: real-world, single-arm study of over 100 sessions
    Nawfel Ayad, Karim Abdel Aziz, Samer Makhoul, Ban Abbas, Syed Fahad Javaid · 2026 · BJPsych Open
17. Ultrasonic Neuromodulation for Network Treatments of Psychiatric and Neurological Disorders
    Jan Kubanek · 2026 · Biological Psychiatry
18. Somatostatin-expressing neurons in the zona incerta regulate chronic stress response and modulate depression-like behaviors
    Hongling Guo, Tahir Ali, Qixing Yang, Jianxun Xia, Yanhua Luo, Jiayan Ren, Zuxin Chen, Ying Han, Shupeng Li · 2026 · Molecular Psychiatry
19. Efficacy and safety of transcranial direct current stimulation (tDCS) on treatment-resistant depression (TRD): A systematic review and Meta-analysis of randomized clinical trials
    Reza Moshfeghinia, Ramtin Naderian, Amirhossein Najibi, Hoorad Mohagheghzadeh, Kiarash Kavari, Saghar Elmi, Armina Torabian, Sanaz Parizan, Saeed Abdollahifard, Konstantin V. Slavin et al. · 2026 · Journal of Affective Disorders
20. Pharmacogenomics and its Future Implications in Treatment-resistant Depression
    Prasad Narayana Shetty · 2016 · Indian Journal of Private Psychiatry
21. Introducing Braining—physical exercise as adjunctive therapy in psychiatric care: a retrospective cohort study of a new method
    Åsa Anger, Anna Wallerblad, Leida Kaaman, Rebecka Broman, Johan Holmberg, Tobias Lundgren, Sigrid Salomonsson, Carl Johan Sundberg, Lina Martinsson · 2023 · BMC Psychiatry
22. Depression-reminiscent Behavior Induced by Chronic Unpredictable Mild Stress Paradigm in Mice Substantially Abrogated by Diosmin
    Abhishek Sharma, Dinesh Dhingra, Rubina Bhutani, Amit Kumar Nayak, Adish Garg · 2024 · Current Psychiatry Research and Reviews
23. Opioid Overdoses and Take-Home Naloxone Interventions: Ethnographic Evidence for Individual-Level Barriers to Treatment of Opioid Use Disorders in Rural Appalachia
    Victor García, Lisa McCann, Erick Lauber, Christian Alexander Vaccaro, Melissa Swauger, Daniel Alex Heckert · 2024 · Substance Use & Misuse
24. Herpes simplex reactivation triggers symptom exacerbation in patients with major depressive disorder
    Ehraz Anis, LeAnn Smart, Colt D. Capan, Cameron Forton, Martha L. Escobar Galvis, Qiong Sha, Eric D. Achtyes, Lena Brundin · 2024 · Journal of Affective Disorders Reports
25. Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study
    Albino Jorge Oliveira-Maia, Benoît Rive, Yordan Godinov, Siobhán Mulhern-Haughey · 2024 · Frontiers in Psychiatry
26. Combination of rTMS and oxytocin agonist attenuate depression-like behavior after postpartum depression in mice
    Nashwa Amin, Alemayehu Hussein, Qing Ye, Shijia Chen, Fei Wu, Xia Yuan, Irum Naz Abbasi, Javaria Sundus, Zhiying Hu, Marong Fang · 2025 · Brain Research
27. The Role of Brain Derived Neurotrophic Factor Polymorphism in Transcranial Magnetic Stimulation Response for Major Depressive Disorder
    Megan M. Vigne, Jamie Kweon, Andrew M. Fukuda, Joshua C. Brown, Linda L. Carpenter · 2025 · Journal of Ect
28. Korean Mistletoe (Viscum album var. coloratum) Ethanol Extracts Enhance Intestinal Barrier Function and Alleviate Inflammation
    Ye Jin Yang, Jong Min Kim, Ji Woong Heo, Hun Hwan Kim, Gon Sup Kim, Minsub Shim, Kwang-Youn Kim, Kwang‐Il Park · 2025 · Antioxidants
29. Switching antidepressants in patients with treatment-resistant depression
    Daniel Souery, William Pitchot · 2022 · Elsevier eBooks
30. Artemisinin exerts antidepressant-like effects via activation of AKT and ERK signaling pathways
    Ruohong Lin, Zhiwei Zhou, Yizhou Jiang, Song Liu, Jinfeng Xie, Haitao Wang, Henning Ulrich, Wenhua Zheng · 2025 · Frontiers in Pharmacology
31. Effects of electroconvulsive shock on the function, circuitry, and transcriptome of dentate gyrus granule neurons
    Adrienne N. Santiago, Julia Castello Saval, Phi Nguyen, Hannah M. Chung, Shaharia Khan, Victor M. Luna, René Hen, Wei-li Chang · 2026 · Neuropsychopharmacology
32. The role of methylphenidate in depression
    Meghan Ellinger May, Amy VandenBerg · 2015 · Mental Health Clinician
33. Immunomodulatory T cell death associated gene-8 (TDAG8) receptor in depression-associated behaviors
    Katherine M.J. McMurray, Lauren Larke Vollmer, Rebecca A. Ahlbrand, Joshua D. Thomas, A. Scott Winter, Ian Paul Lewkowich, Renu Sah · 2019 · Physiology & Behavior
34. A National Retrospective Study of Antidepressants’ Effects on Overdose and Self-Harm Among Adults Treated With Opioid Analgesics
    Tisamarie B. Sherry, Thuy Dieu Nguyen, Andrew W. Dick, Ashley C. Bradford, Kosali Ilayperuma Simon, Bradley D. Stein · 2022 · Psychiatric Services
35. Syringic Acid Reversed Depression-Resembling Behavior Induced by Chronic Unpredictable Mild Stress Paradigm in Mice
    Abhishek Sharma, Dinesh Dhingra, Rohit Dutt · 2021 · International Journal of Pharmaceutical Sciences and Drug Research
36. Influence of Vagus Nerve Stimulation on Mood and Associated Disorders
    Sarah A. Bottari, Alex Rodriguez, John B. Williamson · 2023 · Neuromethods
37. In Silico Study of the 5-Hydroxytryptamine-2C Receptor Antagonist Activity of Anthocyanins as Antidepressant Therapy
    Nia Kurnianingsih, Novita Titis Harbiyanti, Ardani Galih Prakosa, Retty Ratnawati · 2023 · Journal of Materials in Life Sciences (JOMALISC)
38. Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder
    Kaniz Farzana Supti, Md. Asaduzzaman, Farhana Islam Suhee, Mohammad Shahriar, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, MMA Shalahuddin Qusar, Md. Rabiul Islam · 2023 · Clinical Pathology
39. The role of immunometabolism in HIV-associated depression and cognitive impairment
    Mohammad Sobhan Sheikh Andalibi, Ronald J. Ellis · 2024 · Elsevier eBooks
40. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2024 · F1000Research
41. Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders
    Jeetendra Kumar Gupta, Kuldeep Singh, Alok Bhatt, Prateek Porwal, Rekha Rani, Anubhav Dubey, Divya Jain, Sachchida Nand · 2024 · 3 Biotech
42. Examining memory reconsolidation as a mechanism of nitrous oxide’s antidepressant action
    Ella Williams, Uršulė Taujanskaitė, Sunjeev K. Kamboj, Susannah Elinor Murphy, Catherine J. Harmer · 2025 · Neuropsychopharmacology
43. An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine
    Salim Sheikh, Sonone Pankaj, Chakra Dhar Tripathi, Verma Veena, Karim Bushra Ahmed · 2020 · Annals of Psychiatry and Treatment
44. Depressive Disorders: Prevalence, Costs, and Theories
    Clara Grosso, Patrı́cia Valentão, Paula B. Andrade · 2016 · Springer eBooks
45. Attitudes to pharmacological treatments for depression
    Kelly Graziani Giacchero Vedana, Daniel Fernando Magrini, Adriana Inocenti Miasso, Ana Carolina Guidorizzi Zanetti, Tatiana Longo Borges · 2017 · British Journal of Mental Health Nursing
46. QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice
    Mariana G. Fronza, Manoela Sacramento, Diego A.C. Alves, Domenico Praticò, Lucielli Savegnago · 2022 · Molecular Neurobiology
47. Translating GWAS Findings Into Therapies For Depression And Anxiety Disorders: Drug Repositioning Using Gene-Set Analyses Reveals Enrichment Of Psychiatric Drug Classes
    Hon‐Cheong So, Alexandria Lau, Carlos Kwan‐Long Chau, Sze‐Yung Wong · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
48. L-methylfolate in patients with treatment resistant depression: fulfilling the goals of personalized psychopharmacological therapy
    Samet Köse, Kemal Sayar · 2018 · Psychiatry and Clinical Psychopharmacology
49. Dynamic behavioral and molecular changes induced by chronic stress exposure in mice
    Thomas Damien Prevot, Dipashree Chatterjee, Jaime Knoch, Sierra A. Codeluppi-Arrowsmith, Keith A. Misquitta, Corey Fee, Dwight F. Newton, Hyunjung Oh, Etienne L. Sibille, Mounira Banasr · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
50. EEG biomarkers of reduced inhibition in human cortical microcircuits in depression
    Frank Mazza, Taufik A. Valiante, John David Griffiths, Etay Hay · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
51. Increased entrainment and decreased excitability predict efficacious treatment of closed-loop phase-locked rTMS for treatment-resistant depression
    Xiaoxiao Sun, Jayce Doose, Josef Faller, James R. McIntosh, Golbarg T. Saber, Sarah M. Huffman, Spiro P. Pantazatos, Han Yuan, Robin I. Goldman, Truman R. Brown et al. · 2023 · medRxiv
52. Biomarkers predict the efficacy of closed-loop rTMS treatment for refractory depression
    Paul Sajda, Xiaoxiao Sun, Jayce Doose, Josef Faller, James R. McIntosh, Golbarg T. Saber, Sarah M. Huffman, Spiro P. Pantazatos, Han Yuan, Robin I. Goldman et al. · 2023 · Research Square
53. Serotonergic psychedelics for depression: A comprehensive overview
    Wingert, A.M., Agnorelli, C., Peill, J., Reed, S., Nutt, D.J., Erritzoe, D. · 2025 · International Review of Neurobiology
54. Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX)
    Laura Sakalauskaitė, Luna Skytte Hansen, Julie Margrethe Dubois, Malina Ploug Larsen, Gustavo M. Feijóo Carrillo, Marcus Schultz Carstensen, Kamilla Woznica Miskowiak, Mai Nguyen, Line Katrine Harder Clemmensen, Paul Michael Petersen et al. · 2024 · Annals of Medicine
55. A Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression
    Julia Laszcz, Chenyang Wang, Patricio Riva‐Posse, Jonathan Kim, Valeriya Tsygankova, Ally Mandell, Hanna Rice, Adriana Patricia Hermida, Brandon M. Kitay, Andrea L. Crowell et al. · 2025 · Journal of Ect
56. Investigating the effects of group dance movement therapy sessions in adults living with treatment resistant depression: A mixed method case series
    Neha Christopher, Jeanette Tamplin, Ella Dumaresq, Sherry W. Goodill · 2025 · The Arts in Psychotherapy
57. Predicting treatment response in individuals with major depressive disorder using structural MRI-based similarity features
    Sutao Song, Songling Wang, Jingjing Gao, Lingkai Zhu, Wenxin Zhang, Yan Wang, Donglin Wang, Danning Zhang, Kangcheng Wang · 2025 · BMC Psychiatry
58. New insights into the molecular pathophysiology and treatment of depression
    Bornika Chattaraj, Sachin Karmakar, Rajiv Jash · 2025 · Neuroscience
59. Reverse Translation
    Brian D. Kangas · 2025 · Perspectives on Behavior Science
60. (Es)ketamine as a treatment for depressive episodes with psychotic features: systematic review
    Henrique Castro Santos, Alexandra Rodrigues, Tiago Luís Gonçalves Neves Machado, Manuel Gonçalves‐Pinho, Allan Hunter Young, Mário F. Juruena · 2025 · BJPsych Open
61. Reduced prevalence of periodontitis in antidepressant users: Findings from a large‐scale US sample
    María Martínez, David Fraguas, Elena Figuero, Francesco D’Aiuto · 2025 · Journal of Periodontology
62. A Prognostic Theory of Treatment Response for Major Depressive Disorder: A Dynamic Systems Framework for Forecasting Clinical Trajectories
    Harold Ngabo-Woods, Larisa Dunai, Isabel Seguí Verdú · 2025 · Applied Sciences
63. Brain tumors: diagnosis and treatment
    Ankit Kumar Dubey, Bairong Shen, Rajeev Kumar Singla · 2025 · Elsevier eBooks
64. Pharmacogenetic Testing to Optimise Antidepressant Treatment in Children and Adolescents: A Narrative Review
    J. Perez, M. Gonzalez, Sofía Ramirez · 2024 · Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology
65. Deep Brain Stimulation of Lateral Habenula Ameliorates Depression-like Symptoms in Rats: Involvement of Mesolimbic Circuit
    Hemant S. Kanhere, Dadasaheb M. Kokare, Yogesh R. Jogdand, Biru B. Dudhabhate, Nishikant K. Subhedar · 2026 · Neurochemical Research
66. A Multimodal Framework for Prognostic Modelling of Mental Health Treatment and Recovery Trajectories
    Harold Ngabo-Woods, Larisa Dunai, Isabel Seguí Verdú, Liang Sui · 2026 · Applied Sciences
67. Systematic Review of Methylenetetrahydrofolate Reductase (MTHFR) 677C>T and 1298A>C Variants and Treatment-Resistant Depression: Insights for Precision Psychiatry
    Juliana Brum Moraes, Carlos Eduardo Coral de Oliveira, Daniela Frizon Alfieri, LUISA MANFREDIN VILA, Euzébio N.J., Edna Maria Vissoci Reiche, Sandra Odebrecht Vargas Nunes · 2026 · Complex Psychiatry
68. Identifying predictive proteomic biomarkers of selective serotonin reuptake inhibitor treatment effect in depression
    Seungyeon Lee, Sora Mun, Yeeun Yun, Doojin Kim, Jiyeong Lee, Hee‐Gyoo Kang · 2026 · Biomarkers in Medicine
69. Microglia associated research in depression: an exploratory trends analysis
    Yan-Jun Chen, Qin-Quan Zhu, Ming-Rong Xie, Di Zhang, YUN-FEI SHUAI, Y H Li, Nan Zhang, Weixing He, Yanhong Liao, Qing-Jia Zeng et al. · 2026 · Frontiers in Aging Neuroscience
70. Not a Standalone Treatment: Considerations for Psychedelic‐Assisted Therapy
    Sharon Murphy, Elizabeth Stewart, Jacqueline Ruth. Winship, Laura Kampel, Benjamin Stiel, Justine Ellis · 2026 · Brain and Behavior
71. Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data
    Ting-Hui Liu, Hong-Shiang Shen, Jheng‐Yan Wu, Po‐Yu Huang, Yu-Ju Shih, Chih-Cheng Lai · 2026 · Translational Psychiatry
72. Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
    Linda Xing Yu Liu, Marina Golts, Virginia Fernandes · 2021 · Pharmacy
73. Korean Medication Algorithm Project for Depressive Disorder 2021 (V): Antidepressant Choices According to Safety, Adverse Effect, Comorbid Physical Illnesses and Clinical Definition of Treatment Resistant Depression
    Myung Hun Jung, Jung Goo Lee, Won‐Myong Bahk, Young Sup Woo, Sheng‐Min Wang, Jong‐Hyun Jeong, Won Kim, Se-Hoon Shim, Jeong Seok Seo, Seung-Ho Jang et al. · 2021 · 신경정신의학
74. The role of ketamine as an antidepressant agent
    Tjokorda Gde Agung Senapathi, Made Gede Widnyana, Luh Nyoman Alit Aryani, Christopher Ryalino · 2023 · Bali Journal of Anesthesiology
75. Utilization of Ketamine for Major Depression
    Ryan Dao, Amit Aggarwal · 2023 · Journal of Exploratory Research in Pharmacology
76. Psychotherapy, pharmacotherapy, and their combination in the treatment of major depressive disorder: How well are we making use of available therapies?
    Ingrid Nădășan, Gabriel Hancu · 2023 · Acta Marisiensis. Seria Medica
77. The Causal Role of Adiposity in Mental Illness: A Systematic Review and Meta‐Analysis of Mendelian Randomization Studies
    Min Gao, Paul Doody, Dimitrios A. Koutoukidis, Yebo Yu, Paul N Aveyard, Richard Stevens, Padraig Dixon · 2026 · Obesity Reviews
78. Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal spray
    Lisa Harding, Maryia Zhdanava, Aditi Shah, Jacqueline A. Pesa, Todor I. Totev, Anabelle Tardif‐Samson, Dominic Pilon, Kruti Joshi · 2024 · Current Medical Research and Opinion
79. Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH)
    Md. Rabiul Islam, Christos Markatos, Ioannis C. Pirmettis, Minas S. Papadopoulos, Vlasios Karageorgos, George Liapakis, Hesham T. Y. Fahmy · 2024 · Molecules
80. The Role of Ketamine in Treatment-resistant Depression: A Narrative Review
    Ashwini Reddy, Swati G. Patel, Amiya Kumar Barik, Priya Thappa, Kiran Jangra, Kirandeep Kaur, Rajeev Chauhan, Ankur Luthra · 2024 · Journal of Exploratory Research in Pharmacology
81. Treatment with combined exercise in patients with resistant major depression (TRACE-RMD): study protocol for a randomised controlled trial
    Nagore Iriarte‐Yoller, José Etxaniz‐Oses, Cristobal Pavón, Mikel Tous‐Espelosin, Pedro M. Sanchez, Sara Maldonado‐Martín, Ana B. Yoller, Edorta Elizagárate Zabala · 2024 · Trials
82. Comparative impact of exercise variants on depressive symptoms in cancer patients: A systematic review and network meta-analysis
    Hao Zhang, Zeyong Hu, JIAO JIAN TONG, Jianhong Hu, Xinchao Wang, Bingnan Wang · 2024 · European Journal of Oncology Nursing
83. A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors
    Marco Calabrò, Chiara Fabbri, Alessandro Serretti, Siegfried F. Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis P. Ferentinos et al. · 2025 · Psychiatric Genetics
84. Neurocomputational Modelling of EEG Connectivity: Links Between Depression, Inflammation, and Gut-Microbiome
    Zohreh Doborjeh, Daniel lavin, Kirsty A. Hunter, Nadja Heym, Bryony C. Heasman, Maryam Doborjeh, Nikola Kirilov Kasabov, Glenn R. Gibson, Alexander Luke Sumich · 2025 · Lecture notes in computer science
85. Metabolic resilience: liraglutide’s potential in alleviating depressive symptoms
    Omar Gammoh, Esam Y. Qnais, Alaa A. A. Aljabali, Taher Hatahet, Abdelrahim M. Alqudah · 2025 · Molecular Biology Reports
86. Religious Wear (Uniforms) in Psychiatry
    Helen Bright · 2014 · Open Journal of Psychiatry
87. A Naturalistic Evaluation of Change in Antidepressant Prescription in Patients With Affective and Anxiety Disorders in a Tertiary Care Hospital of India
    Amol Patil, Swapnajeet Sahoo, Gaurav Garg, Sandeep Grover · 2017 · Journal of Clinical Psychopharmacology
88. The Effect of Repetitive Transcranial Magnetic Stimulation on Meta-Worry and Neuropsychological Functions among Patients with Depression
    Mahboobeh Majdi, Maryam Bakhtiyari, Reza Rostami, Abbas Masjedi Arani, Mohsen Saberi · 2021 · Iranian Red Crescent Medical Journal
89. The Influence of Research Follow-Up during COVID-19 Pandemic on Mental Distress and Resilience: A Multicenter Cohort Study of Treatment-Resistant Depression
    Phạm Thị Thu Hương, Chia‐Yi Wu, Ming‐Been Lee, Wei‐Chieh Hung, I‐Ming Chen, Hsi‐Chung Chen · 2022 · International Journal of Environmental Research and Public Health
90. Safety and efficacy of ketamine-augmented electroconvulsive therapy in third trimester pregnancy complicated by COVID-19
    Ashmi Patel, Anna Claire Saucier, Christopher D. Hobday, Ranjit C. Chacko · 2022 · Baylor University Medical Center Proceedings
91. Agomelatine Changed the Expression and Methylation Status of Inflammatory Genes in Blood and Brain Structures of Male Wistar Rats after Chronic Mild Stress Procedure
    Katarzyna I. Białek, Piotr Lech Czarny, Paulina Wigner, Ewelina Synowiec, Łukasz Kołodziej, Michał Bijak, Janusz Szemraj, Mariusz Papp, Tomasz Śliwiński · 2022 · International Journal of Molecular Sciences
92. Comparative efficacy of high-frequency repetitive transcranial magnetic stimulation to left dorsolateral prefrontal cortex as an augmentation strategy versus pharmacological augmentation in non-psychotic, unipolar, treatment-resistant depression: A randomized controlled trial
    Amit Chail, P. Bhat, Harpreet Singh, R. K. Saini · 2022 · Industrial Psychiatry Journal
93. Improvements in Depressive Symptoms in Nature May Be Partly Caused by Improvements in Vagal Tone: A Review and Theoretical Perspective
    Devon Jecmen, Sara B. LoTemplio · 2023 · Ecopsychology
94. Interventional Mental Health: A Transdisciplinary Approach to Novel Psychiatric Care Delivery
    Jonathann C. Kuo, Tabitha Block, Megan Nicklay, Brandon Lau, Marcel Green · 2023 · Cureus
95. Effects of Emotionally Focused Therapy on Emotional Autonomy and Emotion Regulation of Students with Depression Symptoms
    Fatemeh Seyed Mousavi, Marzieh Talebzadeh Shoushtari, Sahar Safarzadeh · 2024 · Journal of Clinical Research in Paramedical Sciences
96. What predicts response to sertraline for people with depression in primary care? a secondary data analysis of moderators in the PANDA trial
    Charlotte Archer, David S. Kessler, Gemma Lewis, Ricardo Araya, Larisa Duffy, Simon M. Gilbody, Glyn Lewis, Tony Kendrick, Tim J. Peters, Nicola Wiles · 2024 · PLoS ONE
97. The Impact of Inflammation on Brain Function and Behavior in Rodent Models of Affective Disorders
    Farheen Farzana, Thibault Renoir, Anthony John Hannan · 2018 · Elsevier eBooks
98. Incensole derivatives from frankincense: Isolation, enhancement, synthetic modification, and a plausible mechanism of their anti-depression activity
    Najeeb Ur Rehman, Sulaiman Al‐Shidhani, Nasiara Karim, Ajmal Khan, Imran Khan, Sobia Ahsan Halim, Sajid Khan Sadozai, Satya Kumar Avula, René Csük, Ahmed Al‐Harrasi · 2022 · Bioorganic Chemistry
99. The Affective Disorder Test: a new test to assess depression and anxiety-like behaviour in rats
    Katie Blackburne · 2021 · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare)
100. Study protocol on the efficacy of exergames-acceptance and commitment therapy program for the treatment of major depressive disorder: Comparison with acceptance and commitment therapy alone and treatment-as-usual in a multicentre randomised controlled trial
     Zhang, Bingyu, Deng, Hongdu, Ren, Jinli, Legrand, Fabien D, Ahmad Yusof, Hazwani, Zhang, Ruiling, Leong Bin Abdullah, Mohammad Farris Iman · 2024 · BMJ Open